Search
Scientific Papers | Contact | What's New | Careers | Investor Relations | Sites | Services | About Patheon 
 
SectionBanner_Investors.jpg
Home / Investor Relations
Investor

Investor-Relation_S2.jpg

 

Investor-Relation_L

Investor Relations
Company Profile
News Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
Investor FAQs
Contact Us

 Investor Relations

Patheon is the leading publicly listed provider of drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. The company’s strategic vision is to become the industry’s best provider of pharmaceutical development and manufacturing services. View more »

View all »   RSSRecent Releases

May 9, 2012
Patheon transformation continues with adjustments to its global platform

Mar 13, 2012
Patheon Announces Annual and Special Shareholder Meeting Web Cast

Stock Quote (TSX: PTI)
Price:
1.77
Change:
- 0.02
Day High:
1.85
Day Low:
1.75
Volume:
28,400
3:13 PM ET on May 16, 2012
Delayed at least 20 minutes.
Provided by eSignal.
Stock price graph
     
   

Copyright 2007 by Patheon Inc. | Terms Of Use | Privacy Statement | About this Website | Login